Valuation (31%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -3.47 | 12.73 |
| PEG Ratio (TTM) | -1.18 | 2.94 |
| P/S Ratio (TTM) | 2.82 | 4.32 |
| P/B Ratio (TTM) | 1.04 | 2.91 |
| P/FCF Ratio (TTM) | 13.07 | 32.54 |
| Price to 5YR AVG Earnings Ratio | N/A | 36.85 |
| Price to 5YR AVG FCF Ratio | N/A | 21.85 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -22.23% | 11.75% |
| ROE (TTM) | -31.38% | 21.84% |
| Net Profit Margin (TTM) | -65.88% | 19.03% |
| ROIC 5YR AVG | N/A | 30.69% |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -469.82% | -193.09% | N/A |
| Revenue | -2.56% | 54.32% | N/A |
| Net Income | -479.78% | -195.12% | N/A |
| Cash Flow | 9.73% | 110.11% | N/A |
Health (63%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.26 | 1.94 |
| Quick Ratio (TTM) | 3.26 | 1.82 |
| D/E Ratio (TTM) | 0.01 | 0.45 |
| Interest Coverage (TTM) | -0.70 | 23.17 |
| Piotroski F-Score | 6 | 5 |
| Altman Z-Score | 1.98 | 3.12 |
| LTL to 5YR AVG FCF | N/A | 16.73 |
| Shares Outstanding Growth 5YR AVG | N/A | 21.31% |